Search

Your search keyword '"Qiu, Jiangdong"' showing total 79 results
Start Over Author "Qiu, Jiangdong"
79 results on '"Qiu, Jiangdong"'

53. Extended validity of weak measurement

Author

Qiu, Jiangdong, primary, Ren, Changliang, additional, Li, Zhaoxue, additional, Xie, Linguo, additional, He, Yu, additional, Zhang, Zhiyou, additional, and Du, Jinglei, additional

Published
2020
Full Text
View/download PDF

62. Novel discoveries targeting gemcitabine‐based chemoresistance and new therapies in pancreatic cancer: How far are we from the destination?

Author

Luo, Wenhao, primary, Yang, Gang, additional, Qiu, Jiangdong, additional, Luan, Jingyang, additional, Zhang, Ying, additional, You, Lei, additional, Feng, Mengyu, additional, Zhao, Fangyu, additional, Liu, Yueze, additional, Cao, Zhe, additional, Zheng, Lianfang, additional, Zhang, Taiping, additional, and Zhao, Yupei, additional

Published
2019
Full Text
View/download PDF

76. Determination of the focused beam waist of lasers with weak measurements

Author

Xie, Linguo, Qiu, Xiaodong, Qiu, Jiangdong, Zhang, Zhiyou, Du, Jinglei, and Gao, Fuhua

Abstract

In this Letter, a method for detecting the focused beam waist of lasers is proposed by using weak measurements based on the so-called weak-value amplification. We establish a propagation model to describe the quantitative relation between the beam waist and the amplified shift of the spin Hall effect of light (SHEL), which is sensitive to the variation of the beam waist. We experimentally measure the amplified shift corresponding to a different beam waist and the experimental data agrees well with theoretical calculation. These results confirm the rationality and feasibility of our method.

Published
2015

77. Epidemiology of pancreatic cancer: New version, new vision.

Author

Luo W, Wang J, Chen H, Ye L, Qiu J, Liu Y, Wang R, Weng G, Liu T, Su D, Tao J, Ding C, You L, and Zhang T

Abstract

Pancreatic cancer (PC) is a devastating malignancy with an extremely high mortality rate and poses significant challenges to healthcare systems worldwide. The prevalence of PC risk factors spiked over the years, leading to a global increase in PC incidence rates. The contribution of different risk factors, however, varied from region to region due to genetic predisposition, environmental, social, and political factors underlying disease prevalence in addition to public health strategies. This comprehensive review aims to provide a thorough analysis of the epidemiology of PC, discussing its incidence, risk factors, screening strategies and socioeconomic burden. We compiled a wide range of seminal studies as well as epidemiological investigations to serve this review as a comprehensive guide for researchers, healthcare professionals, and policymakers keen for a more profound understanding of PC epidemiology. This review highlights the essentiality of persistent research efforts, interdisciplinary collaboration, and public health initiatives to address the expanding burden of this malignancy., (Copyright ©2023 Chinese Journal of Cancer Research. All rights reserved.)

Published
2023
Full Text
View/download PDF

79. Novel therapies targeting hypoxia mechanism to treat pancreatic cancer.

Author

Luo W, Qiu J, Zheng L, and Zhang T

Abstract

Pancreatic cancer (PC) is one of the deadliest malignancies. The high mortality rate of PC largely results from delayed diagnosis and early metastasis. Therefore, identifying novel treatment targets for patients with PC is urgently required to improve survival rates. A major barrier to successful treatment of PC is the presence of a hypoxic tumor microenvironment, which is associated with poor prognosis, treatment resistance, increased invasion and metastasis. Recent studies have identified a number of novel molecules and pathways in PC cells that promote cancer cells progression under hypoxic conditions, which may provide new therapy strategies to inhibit the development and metastasis of PC. This review summarizes the latest research of hypoxia in PC and provides an overview of how the current therapies have the capacity to overcome hypoxia and improve PC patient treatment. These findings will eventually provide guidance for future PC management and clinical trials and hopefully improve the survival of patients with PC., Competing Interests: Conflicts of Interest: The authors have no conflicts of interest to declare., (Copyright ©2021Chinese Journal of Cancer Research. All rights reserved.)

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results